Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SHP2 is a non-receptor protein tyrosine phosphatase encoded by the PTPN11 gene. It is ubiquitously expressed and plays a central role in cell signaling downstream of RTKs and cytokine receptors. SHP2 regulates key cellular processes such as growth, proliferation, differentiation, survival, and migration through its modulation of pathways like RAS/MAPK, PI3K/AKT, and JAK/STAT. Mutations in PTPN11 are implicated in Noonan Syndrome, LEOPARD Syndrome, and various cancers. It is considered an attractive drug target for cancer therapy.
Inhibition of SHP2 phosphatase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Src Homology-2 Domain-Containing Protein Tyrosine Phosphatase 2 (SHP2).